Clinical Trials Browser

Recruiting × OTHER × ADI PEG20 × Clear all

NCT03970447 2025-09-09

GBM AGILE

Phase 2/3 Recruiting

Glioblastoma, Recurrence

NCT06034977 2023-09-13

Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular